LV-CAG-GCaMP6s-IRES-Puro

What it means: CAG is the CMV enhancer / chicken beta-actin hybrid promoter, a very strong, ubiquitous promoter built from the CMV enhancer, the chicken beta-actin promoter and a rabbit beta-globin splice acceptor.

Why it matters:

• The promoter sets where and how strongly the cassette is expressed after transduction.
• CAG drives robust expression in most mammalian cell types and in vivo.
• Promoter choice also affects how quickly expression appears and whether it persists after weeks in culture or in vivo.

How to interpret here: in LV-CAG-GCaMP6s-IRES-Puro, CAG drives GCaMP6s, so expect the expression pattern described above in transduced cells.

Tip: when comparing constructs, keep the promoter constant — differences between CAG and another promoter can be larger than the effect of the transgene itself.

What it means: GCaMP6s is a genetically encoded calcium indicator whose fluorescence rises with intracellular calcium, allowing optical recording of cell activity.

Why it matters:

• GCaMP6s reports activity rather than simply marking cells: fluorescence rises when intracellular calcium rises.
• Baseline GCaMP6s fluorescence in resting cells is low by design, so it is a poor measure of transduction efficiency or copy number.
• Recording needs time-series imaging with a stable baseline; report signal as a change from baseline rather than as absolute brightness.

How to interpret here: transduced cells express GCaMP6s, but the signal you see depends on the calcium level at the moment of measurement, not on expression level alone.

Tip: to confirm transduction independently of activity, apply a stimulus known to raise calcium rather than relying on resting GCaMP6s brightness, which is low by design.

What it means: Constitutive — expression is continuous and not dependent on an inducer or recombinase.

Why it matters:

• No additional reagent or driver line is needed; expression begins after integration and continues in daughter cells.
• No inducer, recombinase, driver line or partner construct is needed, which keeps the experiment simple.
• The trade-off is that expression cannot be switched off or timed, so it continues from integration onward in every transduced cell.

How to interpret here: LV-CAG-GCaMP6s-IRES-Puro expresses its cassette continuously from the CAG promoter as soon as it has integrated.

Tip: compare against a control vector with the same backbone, promoter and selection marker rather than against untransduced cells, so transduction and selection effects can be separated from the cassette effect; ask us if a matching control is not listed.

What it means: Puromycin — puromycin N-acetyltransferase (pac) confers resistance to puromycin.

Why it matters:

• Puromycin kills non-transduced mammalian cells quickly, typically within a few days, so stable pools can be selected rapidly.
• The marker decides whether stable pools can be drug-selected and which other markers can be combined in the same cells.
• Selection also removes the untransduced fraction, which simplifies downstream assays that require a uniform population.

How to interpret here: the selection marker for this vector is Puromycin; drug-resistant survivors are the cells that carry the integrated cassette.

Tip: titrate Puromycin on the target cells first (kill curve) — the effective dose varies widely between cell types.

What it means: >1E+9 TU/mL is the functional titer in transducing units (TU) per mL — the number of particles that actually deliver and express the cassette, not the physical particle count.

Why it matters:

• Functional titer is what determines the multiplicity of infection (MOI) you can reach with a given volume.
• The value is stated as a minimum (>1E+9 TU/mL), so treat it as a floor when planning volumes rather than as an exact content figure.
• Functional titers are assay-dependent, so compare titers between vendors only when the titration method is the same.

How to interpret here: calculate MOI from >1E+9 TU/mL and your cell number; optimize MOI per cell type, since transduction efficiency differs between lines and primary cells.

Tip: keep the vector cold during dilution and avoid vortexing — titer loss from repeated freeze-thaw or rough handling is the most common reason a >1E+9 TU/mL stock underperforms.

What it means: BSL-2 is the biosafety containment level required for handling this lentiviral vector.

Why it matters:

• BSL-2 work requires a certified biosafety cabinet, appropriate PPE and decontamination of all waste and surfaces.
• Institutional biosafety approval is usually required before lentiviral work begins, and transfer between labs follows the same containment rules.
• Transduced cells and used media remain BSL-2 material until decontaminated.

How to interpret here: handle LV-CAG-GCaMP6s-IRES-Puro under BSL-2 practices throughout storage, thawing, transduction and disposal.

Tip: check whether your institution requires enhanced BSL-2 practices for lentiviral vectors carrying particular transgenes; this varies between institutions.